Cannabinoid composition and products including α-tocopherol
AssigneeConstance Therapeutics, Inc.
InventorsConstance Finley, Luke McKee
Life of this patent
Estimating the term…
Loading patent…
AssigneeConstance Therapeutics, Inc.
InventorsConstance Finley, Luke McKee
Estimating the term…
A cannabinoid composition having an excipient including α-tocopherol and at least one isolated cannabinoid having a purity of greater than 80%. The α-tocopherol inhibits oxidation, regulates viscosity of the composition, and improves bioavailability of the cannabinoid. The composition includes a carrier oil mixed with the excipient and cannabinoid. In one embodiment, the at least one cannabinoid is an isolated cannabinoid having a greater than 80% purity, and preferably greater than 90% purity. The at least one cannabinoid is selected from the group consisting of phytocannabinoids, endocannabinoids, synthetic cannabinoids, and combinations thereof. The cannabinoid may be derived from plants other than cannabis sativa, or synthesized from fungi, bacteria, yeast or other synthetic method. Preferably the α-tocopherol comprises at least 10% w/w of the composition.
A tablet or capsule consisting essentially of cannabis oil, vitamin e, lemon oil, lavender oil and peppermint oil.
Dependencies are inferred from the claim text.